Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$454.74(as of Sep 4, 1:38 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$454.74
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,230
CountyUSA
Market Cap$58,592.3M
EBIDTA-123.7M
10-Day Moving Average452.25
P/E Ratio-181.83
20-Day Moving Average446.45
Forward P/E Ratio50.00
50-Day Moving Average379.55
Earnings per Share-2.46
200-Day Moving Average290.44
Profit Margin-8.57%
RSI65.38
Shares Outstanding131.1M
ATR12.26
52-Week High469.81
Volume1,232,080
52-Week Low205.87
Book Value250.6M
P/B Ratio231.54
Upper Keltner474.03
P/S Ratio23.57
Lower Keltner418.87
Debt-to-Equity Ratio474.03
Next Earnings Date10/30/2025
Cash Surplus-187.2M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of Sep 04, 2025
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.